California State Teachers Retirement System (CalSTRS)’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3,746
| Closed | -$15K | – | 3067 |
|
|
2025
Q2 | $15K | Hold |
3,746
| – | – | ﹤0.01% | 2588 |
|
|
2025
Q1 | $3.41K | Hold |
3,746
| – | – | ﹤0.01% | 2971 |
|
|
2024
Q4 | $10.4K | Hold |
3,746
| – | – | ﹤0.01% | 2851 |
|
|
2024
Q3 | $19.6K | Hold |
3,746
| – | – | ﹤0.01% | 2615 |
|
|
2024
Q2 | $16.7K | Sell |
3,746
-1,053
| -22% | -$5.11K | ﹤0.01% | 2665 |
|
|
2024
Q1 | $36.8K | Sell |
4,799
-3,059
| -39% | -$16.8K | ﹤0.01% | 2548 |
|
|
2023
Q4 | $33.5K | Buy |
7,858
+389
| +5% | +$1.38K | ﹤0.01% | 2754 |
|
|
2023
Q3 | $31.4K | Sell |
7,469
-3,791
| -34% | -$19.3K | ﹤0.01% | 2878 |
|
|
2023
Q2 | $62.7K | Buy |
+11,260
| New | +$66.6K | ﹤0.01% | 2834 |
|
|
2022
Q2 | – | Sell |
-5,996
| Closed | -$25K | – | 3226 |
|
|
2022
Q1 | $25K | Sell |
5,996
-1,734
| -22% | -$10.2K | ﹤0.01% | 3154 |
|
|
2021
Q4 | $53K | Hold |
7,730
| – | – | ﹤0.01% | 3150 |
|
|
2021
Q3 | $90K | Sell |
7,730
-12,137
| -61% | -$189K | ﹤0.01% | 3021 |
|
|
2021
Q2 | $339K | Buy |
19,867
+1,724
| +10% | +$30K | ﹤0.01% | 2855 |
|
|
2021
Q1 | $359K | Buy |
18,143
+5,845
| +48% | +$129K | ﹤0.01% | 2663 |
|
|
2020
Q4 | $254K | Hold |
12,298
| – | – | ﹤0.01% | 2740 |
|
|
2020
Q3 | $323K | Buy |
+12,298
| New | +$305K | ﹤0.01% | 2502 |
|
California State Teachers Retirement System (CalSTRS)'s INZY Position: Q3 2025 in Review
California State Teachers Retirement System (CalSTRS) sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 3,746 shares — an estimated $15K sold.
California State Teachers Retirement System (CalSTRS) first reported a position in INZY in Q3 2020 and held it in 16 quarters. The position peaked at $359K in Q1 2021. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.
- California State Teachers Retirement System (CalSTRS) reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
- California State Teachers Retirement System (CalSTRS) sold 3,746 Inozyme Pharma shares in Q3 2025, an estimated $15K.
- California State Teachers Retirement System (CalSTRS) first reported a position in Inozyme Pharma in Q3 2020 and held it in 16 quarters.
- California State Teachers Retirement System (CalSTRS)'s Inozyme Pharma position peaked at $359K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q3 2025, filed 14 Nov 2025.